N30 Pharmaceuticals appoints R. Michael Carruthers new CFO

N30 Pharmaceuticals appoints R. Michael Carruthers new CFO

BOULDER - N30 Pharmaceuticals Inc. , a clinical-stage pharmaceutical company focused on developing product candidates for cystic fibrosis, announced R. Michael Carruthers has been appointed... Read More

By: InnovatioNews Friday February 6, 2015 0 comments Tags: Array BioPharma, Boulder, Jon Congleton, N30 Pharmaceuticals, N91115

N30 Pharmaceuticals appoints Jon Congleton to be president and CEO

N30 Pharmaceuticals appoints Jon Congleton to be president and CEO

BOULDER - N30 Pharmaceuticals Inc. , a clinical-stage, biopharmaceutical company focused on development of therapies for cystic fibrosis, announced its board of directors has appointed Jon... Read More

By: InnovatioNews Tuesday December 23, 2014 0 comments Tags: Boulder, cystic fibrosis, Howard Furst, Jon Congleton, N30 Pharmaceuticals